中文

常山药业 Revenue Breakdown

Period 2026-03-31 ・ Reported 2026-04-29
ItemAmountY/Y
Revenue¥0.26B-1.0%
Gross profit¥0.06B
Operating income¥0.00B
Net income¥0.00B+107.8%
Gross margin24.6%Net margin 1.3%
Revenue Q/Q+32.1%

Revenue Segments

The filing did not disclose a revenue breakdown for this period.

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥0.19B75.4%
R&D¥0.01B2.8%
SG&A¥0.03B12.0%
Tax & other¥0.00B0.5%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

星星科技开山股份精锻科技新天科技新莱应材雅本化学隆华科技佳创视讯通光线缆兴源环境尔康制药佳沃食品

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies